Nonsurgical management of usual-type vulval intraepithelial neoplasia

References

• Bowen JT. Precancerous dermatosis – a study of chronic atypical epithelial proliferation. J. Cutan. Dis. Syphilol.30, 241–255 (1912).
   Google Scholar
• Sideri M, Jones RW, Wilkinson EJ et al. Squamous vulvar intraepithelial neoplasia. 2004 modified terminology, ISSVD vulvar oncology subcommittee. J. Reprod. Med.50, 807–810 (2005).
   PubMed Web of Science ®Google Scholar
• Scurry J, Campion M, Scurry B, Kim SN, Hacker N. Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia. Int. J. Gynecol. Pathol.25(2), 176–181 (2006).
   PubMed Web of Science ®Google Scholar
• Maclean A, Reid W. Benign and premalignant disease of the vulva. Br. J. Obstet. Gynaecol.102(5), 359–363 (1995).
   PubMedGoogle Scholar
• Modesitt SC, Waters AB, Walton L, Fowler WC, Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet. Gynecol.93(4), 633–634 (1999).
   PubMedGoogle Scholar
• Chafe W, Richards A, Morgan L, Wilkinson E. Unrecognised invasive carcinoma in vulvar intraepithelial neoplasia. Gynecol. Oncol.31(1), 154–165 (1988).
   PubMed Web of Science ®Google Scholar
• Spirtos NM, Smith LH, Teng NN. Prospective randomised trial of topical αinterferon for the treatment of vulvar intraepithelial neoplasia III. Gynecol. Oncol.37(1), 34–38 (1990).
   PubMed Web of Science ®Google Scholar
• Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet. Gynecol.84, 741–745 (1994).
   PubMed Web of Science ®Google Scholar
• Jones RW. Is vulvar intraepithelial neoplasia a precursor of cancer? In: Cancer and Precancer of the Vulva. Luesley DM (Ed.). Arnold, London, UK, 67–73 (2000).
   Google Scholar
• Van Seters M, van Beurden M, de Craen AJM. Is the assumed natural history of vulvar epithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol. Oncol.97, 645–651 (2005).
   PubMed Web of Science ®Google Scholar
• Jones RW. The natural history of lower genital tract precancers: an historical perspective. In: Lower Genital Tract Neoplasia. MacLean AB, Singer A, Critchley H (Eds). RCOG Press, London, UK (2003).
   Google Scholar
• Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet. Gynecol.90(3), 448–452 (1997).
   PubMed Web of Science ®Google Scholar
• Joura E. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J. Reprod. Med.45(8), 613–615 (2000).
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi A, Freedman D, Miller D et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol. Oncol.84(1), 94–101 (2002).
   PubMed Web of Science ®Google Scholar
• Stanley M. Genital human papillomavirus infections – current and prospective therapies. J. Natl Cancer Inst. Monographs31, 117–124 (2003).
   PubMedGoogle Scholar
• Chenoy R, Luesley DM. Vulvar and multifocal intraepithelial neoplasia. In: Intraepithelial Neoplasia of the Lower Genital Tract. Luesley DM, Jordan J, Richart RM (Eds). Churchill Livingstone, Edinburgh, UK (1995).
   Google Scholar
• Krebs HB, Helmkamp BF. Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions. Obstet. Gynecol.78, 205–208 (1991).
   PubMed Web of Science ®Google Scholar
• Wendling J, Saiag P, Berville-Levy S, Bourgault-Villada I, Clerici T, Moyal-Barracco M. Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases. Arch. Dermatol.140(10), 1220–1224 (2004).
   PubMedGoogle Scholar
• Joura EA, Leodolter S, Hernandez-Avila M et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised trials. Lancet369, 1693–1702 (2007).
   PubMed Web of Science ®Google Scholar
• Van Seters et al. Effectiveness of Imiquimod 5% cream in women with high grade vulvar intraepithelial neoplasia (VIN): final results of a randomised controlled trial. Abstracts of 18th ISSVD Meeting, New Zealand, 2006.
   Google Scholar
• Todd RW, Etherington IJ, Luesley DM. The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecol. Oncol.85 (1), 67–70 (2002).
   PubMed Web of Science ®Google Scholar
• Van Poelgeest MI, van Seters M, van Beurden M et al. Detection of human papillomavirus (HPV) 16-specific CD4+ Tcell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment. Clin. Cancer Res.11(14), 5273–5280 (2005).
   PubMed Web of Science ®Google Scholar
• Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res.61(1), 192–196 (2001).
   PubMed Web of Science ®Google Scholar
• Fiander A, Man S. HPV vaccines. In: Lower Genital Tract Neoplasia. MacLean AB, Singer A, Critchley H (Eds). RCOG Press, London, UK (2003).
   Google Scholar
• Fiander AN, Tristram AJ, Davidson EJ et al. Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter Phase II trial. Int. J. Gynecol. Cancer16, 1075–1081 (2006).
   PubMed Web of Science ®Google Scholar
• Davidson EJ, Boswell CM, Sehr P et al. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res.63(18), 6032–6041 (2003).
   PubMed Web of Science ®Google Scholar
• Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res.55 (3), 224–236 (2007).
   PubMed Web of Science ®Google Scholar
• Naik R, Nixon S, Lopes A, Godfrey K, Hatem MH, Managhan JM. A randomised Phase II trial of indole-3-carbinole in the treatment of vulvar intraepithelial neoplasia. Int. J. Gynecol. Cancer16(2), 786–790 (2006).
   PubMed Web of Science ®Google Scholar
• Tristram A, Fiander A. Clinical responses to cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecol. Oncol.99(3), 652–655 (2005).
   PubMed Web of Science ®Google Scholar
• Bruchim I, Gotlieb WH, Mahmud S, Tunitsky E, Grzywacz K, Ferenczy A. HPV-related vulvar intraepithelial neoplasia: outcome of different treatment modalities. Int. J. Gynaecol. Obstet.99(1), 23–7 (2007).
   PubMed Web of Science ®Google Scholar
• Ljubojevic S. The human papillomavirus vaccines. Acta Dermatovenerol. Croat.14(3), 208 (2006).
   PubMedGoogle Scholar
• Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet. Gynecol.108(6), 1361–1368 (2006).
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med.356(19), 1928–1943 (2007).
   PubMed Web of Science ®Google Scholar
• Jayne CJ, Kaufman RH. Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod. J. Reprod. Med.47(5), 395–398 (2002).
   PubMed Web of Science ®Google Scholar
• Van Seters M, Fons G, van Beurden M. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study. J. Reprod. Med.47(9), 701–705 (2002).
   PubMed Web of Science ®Google Scholar
• Marchitelli C, Secco G, Perrotta M, Lugones L, Pesce R, Testa R. Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream. J. Reprod. Med.49(11), 876–882 (2004).
   PubMed Web of Science ®Google Scholar
• Le T, Hicks W, Menard C, Hopkins L, Fung MF. Preliminary results of 5% imiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3. Am. J. Obstet. Gynecol.194(2), 377–380 (2006).
   PubMed Web of Science ®Google Scholar
• Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study. Gynecol. Oncol.107(2), 219–22 (2007).
   PubMed Web of Science ®Google Scholar
• Hillemans P, Untch M, Dannecker C et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int. J. Cancer85(5), 649–653 (2000).
   PubMed Web of Science ®Google Scholar
• Fehr MK, Hornung R, Schwartz VA, Simeon R, Haller U, Wyss P. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol. Oncol.80(1), 62–66 (2001).
   PubMed Web of Science ®Google Scholar
• Fehr MK, Hornung R, Degen A et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg. Med.30(4), 273–279 (2002).
   PubMed Web of Science ®Google Scholar
• Campbell SM, Gould DJ, Salter L, Clifford T, Curnow A. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia. Br. J. Dermatol.151(5), 1076–1080 (2004).
   PubMed Web of Science ®Google Scholar